WE'RE PARTNERING WITH PROVENTA INTERNATIONAL AT THE DRUG DISCOVERY BIOLOGY STRATEGY MEETING IN LONDON.
CLICK HERE TO USE YOUR VIP CODE FOR FREE REGISTRATION.
Pushing our understanding of the physiological context and quality of drug target characterisation, validation, and safety profiling throughout the preclinical space
2
KEYNOTES
COLLEAGUES
100+
6
TOPIC AREAS
1
LOCATION
INTRODUCING
Real insights are shared in conversations, not lectures. That’s why our unique roundtable format guarantees real learning and ensures you only attend discussions that deliver value to you.
Facilitating all of the thought-provoking roundtables are our board of industry leaders and specialists in the field.
Take a look at some of the experts who will be speaking at our upcoming strategy meeting.
DISCUSSIONS LEAD BY THE EXPERTS
Executive Director, Head of DMPK, Biopharmaceuticals R&D
ASTRAZENECA
Lassina Badolo
Executive Chairman and CEO
MIRZYME THERAPEUTICS
Asif Ahmed
LEO PHARMA
Thorsten Thormann
Vice President
Senior Vice President & Global Head, Research
H. LUNDBECK A/S
Tarek Samad
CEO
AMCURE GMBH
Klaus Dembowsky
Mike Davies
CAROCELL BIO
Founder, CEO
CEO & Founder
EPICOMBI THERAPEUTICS
Steven Zimmer
Magnus Walter
ABBVIE
Head of Screening Biology and Operations
This is certainly no typical conference format. Our unique events provide a modern way of networking and learning.
Intimate and interactive format where every voice is heard.
Stimulate your thinking and collaborate on fresh ideas
Debate Industry challenges through candid discussions
Join industry players from big pharma, biotech, research institutes and CROs...
Gain insights, stay competitive and benchmark against your peers
Structural Biology & Biophysics
In Vivo & In Vitro Pharmacology
DPMK / ADME
Target ID & Validation
External Innovation & Partnering
What you want to know. We speak to our wide network of senior decision-makers to ensure the most important topics are covered:
Join us in May, in person.
Enter the coupon code BB-VIP-2022 for your FREE VIP REGISTRATION
